Learn about the latest advances in diabetes and other endocrine disorders from the expert of the Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease at Mount Sinai. Our physician-scientists are on the leading edge of diabetes discoveries that have immediate impact on our patients. Andrew Stewart, MD, focuses his research on innovative therapies to regenerate insulin-producing pancreatic beta cells. Carol Levy, MD, directed the first clinical trials for the artificial pancreas. Division Chief Andrea Dunaif, MD, is a leading researcher in genes for polycystic ovary syndrome, a major cause of diabetes in women. We also have multidisciplinary centers of excellence in adrenal, pituitary, and thyroid disorders, as well as in weight management.
The Diabetes & Endocrinology Department at the Mount Sinai Hospital is proud to be ranked No. 14 in the nation by U.S. News & World Report Best Hospitals for 2022-23.
Learn about the latest advances in diabetes and other endocrine disorders from the expert of the Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease at Mount Sinai. Our physician-scientists are on the leading edge of diabetes discoveries that have immediate impact on our patients. Andrew Stewart, MD, focuses his research on innovative therapies to regenerate insulin-producing pancreatic beta cells. Carol Levy, MD, directed the first clinical trials for the artificial pancreas. Division Chief Andrea Dunaif, MD, is a leading researcher in genes for polycystic ovary syndrome, a major cause of diabetes in women. We also have multidisciplinary centers of excellence in adrenal, pituitary, and thyroid disorders, as well as in weight management.
The Diabetes & Endocrinology Department at the Mount Sinai Hospital is proud to be ranked No. 14 in the nation by U.S. News & World Report Best Hospitals for 2022-23.
Andrea Dunaif, MD, Chief of the Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, a world leader in the study of disorders of metabolism and reproduction, is heading ...
The Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease at the Icahn School of Medicine at Mount Sinai is dedicated to advancing the understanding and treatment of diabetes, obesity, conditions affecting ...
Mount Sinai was honored by the Juvenile Diabetes Research Foundation at their annual Promise Ball for its type 1 diabetes research and patient care, with particular recognition of Carol J. Levy, MD, and Andrew F. Stewart, MD.
Mount Sinai’s Center for Post-COVID Care is part of a novel, multisite study that is investigating whether abnormal pituitary hormone levels are implicated in post-COVID fatigue, a prevalent and debilitating condition.
In 2022, investigators advanced the understanding of a broad spectrum of topics relevant to diabetes, metabolism, and obesity, including the central nervous system control of metabolism and therapies to regenerate pancreatic beta cells.
Mount Sinai researchers demonstrated that small molecule DYRK1A inhibitors induce human beta cells to replicate by converting the repressive DREAM complex to its pro-proliferative MMB conformation—a crucial advance in the knowledge of this process.
Endocrinologists and other physicians gained important guidance, as the World Professional Association for Transgender Health released the first update of its standards of care in 10 years.
Alice C. Levine, MD, convened an interdisciplinary group of experts in adrenal disorders and neuroendocrine tumors to develop a clinical pathway for the management of Cushing syndrome due to ectopic adrenocorticotropin production.
Use of an automated insulin delivery system improved glucose control among people with type 2 diabetes, representing a potential option for those who are struggling to keep their glucose levels in range.
In an unusual and complex case, a multidisciplinary team developed a treatment for a patient with end-stage liver disease and insulin antibody-mediated insulin resistance.
Emily Gallagher, MD, PhD, received a Method to Extend Research in Time (MERIT) Award from the National Cancer Institute to study the role of high triglyceride levels in driving triple negative breast cancer growth and metastasis.
In a study with the potential to change current practice, a Mount Sinai research team found the risk of blood clots to be minimal, and that patients can safely remain on critical estrogen therapy during their surgery.
A new ambulatory practice, Medicine Multispecialty at Mount Sinai Morningside, was launched in February 2021, dedicated to providing integrated, team-based care that meets the complex needs of patients, especially those with chronic disease.
Two Mount Sinai endocrine surgeons were among the first in the United States to use a novel minimally invasive scar-free thyroidectomy approach, with continuing successful outcomes in more than 100 patients thus far.
Mount Sinai is one of three U.S. sites participating in a clinical trial of an experimental “artificial pancreas” system customized for the stringent glucose targets recommended for optimal maternal and fetal outcomes of pregnancies complicated by diabetes.
When the COVID-19 crisis forced New York hospitals to delay all non-urgent surgeries, clinicians at Mount Sinai’s Adrenal Center were able to safely manage three patients with newly diagnosed pheochromocytomas for longer than the recommended ...
A Q&A with the head of the Healthy Lifestyle Clinic, a weight management program for children and teens with obesity and obesity-related health complications.
The Institute has expanded significantly in the last 10 years as its laboratories investigate the the pathophysiology of both type 1 and type 2 diabetes, and develop better therapeutic and prevention strategies for those who suffer from ...
Mount Sinai researchers are developing a novel two-drug approach to treating diabetes that enables the regeneration of insulin-producing pancreatic beta cells.
The merger of Endocrinology fellowships at Mount Sinai into a system-wide program has created not only the largest training effort of its type in the country, but one offering participants an unmatched diversity of clinical and research ...
The Division of Endocrinology, Diabetes and Bone Disease had a welcome return to more normal operations in 2021. Our superb faculty continue to be at the forefront of developing innovative approaches to provide optimal clinical care for ...
Tamar Reisman, MD, discusses the process of breast development and lactation, endocrine-mediated processes, and a case in which functional lactation was induced in a transgender patient
